BURRELL INTERNATIONAL GROUP LLC

Lobbying for BIOFACTURA, INC. · Biopharmaceutical industry development, scale-up, and manufacturing

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $10,000.00 income · posted Jan 14, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Medical Countermeasure Development for Smallpox and FY26 LHHS Appropriation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.